The second mid-term follow-up study, conducted by Kohva et al (176), described administration of FSH injections twice or thrice weekly for 3 to 4 months combined with a once-monthly injection of testosterone for 3 months to 5 infants with CHH, starting at a mean age of 2.5 months. This evidence concerns the gene BRD2 and cartilage-hair hypoplasia.